Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan(Ovarian Cancer Action), Frances R. Balkwill(Queen Mary University of London), George Coukos(Ludwig Cancer Research), Michael Friedländer(Prince of Wales Hospital), David D.L. Bowtell(The University of Melbourne), Hani Gabra(Royal Children's Hospital), Ernst Lengyel(University of Illinois Chicago), Jonathan S. Berek(Stanford Health Care), Douglas A. Levine(New York University), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Jermaine Coward(Royal Marsden NHS Foundation Trust), Kenneth P. Nephew(Indiana University Health), Ronny Drapkin(University of Pennsylvania), Robert C. Bast(The University of Texas MD Anderson Cancer Center), Amit M. Oza(Ontario Institute for Cancer Research), Euan A. Stronach(Age UK), Usha Menon(University of South Florida), Henning Walczak(CRUK Lung Cancer Centre of Excellence), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Christopher J. Lord(Institute of Cancer Research), Iain A. McNeish(Imperial College London), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Andy Berchuck(Duke Medical Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Christopher Crum(Brigham and Women's Hospital), Stan B. Kaye(Institute of Cancer Research)
Cited by 1,507
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k